1,465
Views
2
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLE

Merging konjac glucomannan with other copolymeric hydrogels as a cutting-edge liquid raft system for dual delivery of etoricoxib and famotidine

, , , , &
Article: 2189630 | Received 16 Jan 2023, Accepted 26 Feb 2023, Published online: 17 Mar 2023

References

  • Aanisah N, Wardhana YW, Chaerunisaa AY, Budiman A. (2022). Review on modification of glucomannan as an excipient in solid dosage forms. Polymers 14:1.
  • Aashigari S, G, R, S, S, Vykuntam U, Potnuri N. (2019). Stability studies of pharmaceutical products. World J Pharm Res 8:479–16.
  • Abou Youssef NAH, Kassem AA, El-Massik MAE, Boraie NA. (2015). Development of gastroretentive metronidazole floating raft system for targeting Helicobacter pylori. Int J Pharm 486:297–305.
  • Abouelatta SM, Aboelwafa AA, El-Gazayerly ON. (2018). Gastroretentive raft liquid delivery system as a new approach to release extension for carrier-mediated drug. Drug Delivery 25:1161–74.
  • Abdelmonem R, Elhabal SF, Abdelmalak NS, et al. (2021). Formulation and characterization of acetazolamide/carvedilol niosomal gel for glaucoma treatment. In Vitro and in Vivo Study. Pharmaceutics 13(2):221–41.
  • Ahmadi M, Bekeschus S, Weltmann K-D, et al. (2022). Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors. RSC Med. Chem 13:471–96.
  • Ain S, Kumar B, Pathak K. (2017). Development and characterization of controlled release famotidine matrix tablets containing complexes. Int J App Pharm 9:38–46.
  • Alvarez-Manceñido F, Landin M, Lacik I, Martínez-Pacheco R. (2008). Konjac glucomannan and konjac glucomannan/xanthan gum mixtures as excipients for controlled drug delivery systems. Diffusion of small drugs. Int J Pharm 349:11–8.
  • Arfan AR, Ilmiawati A, Sugita P. (2022). Optimization and synthesis of etoricoxib-loaded low molecular weight chitosan nanoparticles. Ciência Rural 52.
  • Behera SS, Ray RC. (2016). Konjac glucomannan, a promising polysaccharide of Amorphophallus konjac K. Int J Biol Macromol 92:942–56.
  • Bello AE. (2012). DUEXIS(®) (ibuprofen 800 mg, famotidine 26.6 mg): A new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug. Ther Adv Musculo 4:327–39.
  • Bello AE, Kent JD, Holt RJ. (2015). Gastroprotective efficacy and safety of single-tablet ibuprofen/famotidine vs ibuprofen in older persons. Phys Sportsmed 43:193–9.
  • Bhavsar DN. (2012). Advances in GRDDS: raft forming system a review. J. Drug Delivery Ther 2.
  • Birk JW, Myers M. (2009). A fixed dose combination of ibuprofen and famotidine. Expert Opin Invest Drugs 18:1385–91.
  • Brenner T, Tuvikene R, Fang Y, et al. (2015). Rheology of highly elastic iota-carrageenan/kappa-carrageenan/xanthan/konjac glucomannan gels. Food Hydrocoll 44:136–44.
  • Das A, Nayak AK, Mohanty B, Panda S. (2011). Solubility and dissolution enhancement of etoricoxib by solid dispersion technique using sugar carriers. ISRN Pharm 2011:819765.
  • Dash S, Murthy PN, Nath L, Chowdhury P. (2010). Kinetic modeling on drug release from controlled drug delivery systems. Acta Poloniae Pharma 67:217–23.
  • Deeks ED. (2013). Fixed-dose ibuprofen/famotidine: a review of its use to reduce the risk of gastric and duodenal ulcers in patients requiring NSAID therapy. Clin Drug Investig 33:689–97.
  • Devaraj RD, Reddy CK, Xu B. (2019). Health-promoting effects of konjac glucomannan and its practical applications: a critical review. Int J Biol Macromol 126:273–81.
  • Devi R, Agarwal S. (2019). Some multifunctional lipid excipients and their pharmaceutical applications. Int J Pharm Pharm Sci 11:1–7.
  • Dranca F, Oroian M. (2019). Optimization of pectin enzymatic extraction from Malus domestica “Fălticeni” Apple Pomace with Celluclast 1.5L. Molecules (Basel, Switzerland) 24(11):2158–71.
  • El Nabarawi MA, Teaima MH, El-Monem A, et al. (2017). Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl. Drug Des Devel Ther 11:1081–93.
  • ELhabal SF, Elwy HM, Hassanin S, et al. (2022). Biosynthesis and characterization of gold and copper nanoparticles from Salvadora persica fruit extracts and their biological properties. Int J Nanomed 17:6095–112.
  • Farag M, Bahra A. (2022). Etoricoxib and celecoxib sensitive indomethacin-responsive headache disorders. Headache 62:383–8.
  • Farrow C, Heidel J, Maloney J, Rogers J. (2004). Scalar equations for synchronous Boolean networks with biological applications. IEEE Trans Neural Netw 15:348–54.
  • Gawkowska D, Cybulska J, Zdunek A. (2018). Structure-related gelling of pectins and linking with other natural compounds: a review. Polymers 10:762.
  • Hamdani J, Moës AJ, Amighi K. (2002). Development and evaluation of prolonged release pellets obtained by the melt pelletization process. Int J Pharm 245:167–77.
  • Ibrahim HK. (2009). A novel liquid effervescent floating delivery system for sustained drug delivery. Drug Discov Ther 3:168–75.
  • Islam MS, Narurkar MM. (2011). Solubility, stability and ionization behavior of famotidine. J Pharm Pharmacology 45:682–6.
  • Jaroenkietkajorn U, Mahapokai S, Wichchukit S. (2018). Effect of pectin and gellan gum on particles and added solids’ stability in drinking fermented goat milk. 1–6.
  • Ju Z, Li M, Xu J, et al. (2022). Recent development on COX-2 inhibitors as promising anti-inflammatory agents: the past 10 years. Acta Pharm Sin B 12:2790–807.
  • Kim JS, Cha KH, Kang SY, et al. (2016). In vivo gastric residence and gastroprotective effect of floating gastroretentive tablet of DA-9601, an extract of Artemisia asiatica, in beagle dogs. Drug Des Devel Ther 10:1917–25.
  • Kirschneck C, Küchler EC, Wolf M, et al. (2019). Effects of the highly COX-2-selective analgesic NSAID etoricoxib on human periodontal ligament fibroblasts during compressive orthodontic mechanical strain. Mediat Inflamm 2019:1–14.
  • la Torre LF, Franco-González DL, Brennan-Bourdon LM, et al. (2021). Analgesic efficacy of etoricoxib following third molar surgery: a meta-analysis. Behav Neurol 2021:9536054.
  • Leiman DA, Riff BP, Morgan S, et al. (2017). Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis. Dis Esophagus 30:1–9.
  • Lewis GA, Mathieu D, Phan-Tan-Luu R. (1998). Pharma Experimental Des. Boca Raton: CRC Press.
  • Li B, Xia J, Wang Y, Xie B. (2005). Grain-size effect on the structure and antiobesity activity of konjac flour. J Agric Food Chem 53:7404–7.
  • Liu Z-L, Hu H, Zhuo R-X. (2004). Konjac glucomannan-graft-acrylic acid hydrogels containing azo crosslinker for colon-specific delivery. J Polym Sci A, Polym Chem 42:4370–8.
  • Martina SD, Vesta KS, Ripley TL. (2005). Etoricoxib: a highly selective COX-2 inhibitor. Ann Pharmacother 39:854–62.
  • Menache A. (2000). Healthy human volunteers and informed consent. Med Law 19:532–5. https://pubmed.ncbi.nlm.nih.gov/11143887/
  • Mishra R, Datt M, Pal K, Banthia A. (2008). Preparation and characterization of amidated pectin based hydrogels for drug delivery system. J Mater Sci – Mater Med 19:2275–80.
  • Moganti M, Shivakumar HN. (2021). Oral raft forming in situ gelling system for site specific delivery of calcium. J Drug Delivery Sci Technol 61:102113.
  • Morris E, Nishinari K, Rinaudo M. (2012). Gelation of gellan – a review. Food Hydrocoll 28:373–411.
  • Mostafavi A, Emami J, Varshosaz J, et al. (2011). Development of a prolonged-release gastroretentive tablet formulation of ciprofloxacin hydrochloride: pharmacokinetic characterization in healthy human volunteers. Int J Pharm 409:128–36.
  • Mummaneni V, Vasavada RC. (1990). Solubilization and dissolution of famotidine from solid glass dispersions of xylitol. Int J Pharm 66:71–7.
  • Muthukumar M, Raju DM, Rajendran M. (2003). Optimization of mix proportions of mineral aggregates using Box Behnken design of experiments. Cem Concr Compos 25:751–8.
  • Pereira R, Carvalho A, Vaz DC, et al. (2013). Development of novel alginate based hydrogel films for wound healing applications. Int J Biol Macromol 52:221–30.
  • Phillips, G. O., Williams, P. A. (Eds.). (2009). Handbook of Hydrocolloids. 2nd ed. Abington Hall, Granta Park: Woodhead Publishing.
  • Prajapati VD, Jani GK, Khutliwala TA, Zala BS. (2013). Raft forming system-an upcoming approach of gastroretentive drug delivery system. Journal of Controlled Release: Official Journal of the Controlled Release Society 168:151–65.
  • Rahamathulla M, Saisivam S, Alshetaili A, et al. (2021). Design and evaluation of losartan potassium effervescent floating matrix tablets: In vivo x-ray imaging and pharmacokinetic studies in Albino Rabbits. Polymers 13:3476–92.
  • Rajinikanth PS, Balasubramaniam J, Mishra B. (2007). Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori. Int J Pharm 335:114–22.
  • Rosiaux Y, Jannin V, Hughes S, Marchaud D. (2014). Solid lipid excipients—matrix agents for sustained drug delivery. JCR 188:18–30.
  • Saha D, Bhattacharya S. (2010). Hydrocolloids as thickening and gelling agents in food: a critical review. J Food Sci Technol 47:587.
  • Sapkal SB, Adhao VS, Thenge RR, et al. (2020). Formulation and Characterization of Solid Dispersions of Etoricoxib Using Natural Polymers. Solid dispersions of etoricoxib using natural polymers. Turkish J Pharma Sci 17:7–19.
  • Shah KU, Khan GM. (2012). Regulating drug release behavior and kinetics from matrix tablets based on fine particle-sized ethyl cellulose ether derivatives: an in vitro and in vivo evaluation. Sci World J 2012:842348–56.
  • Shah JC, Sadhale Y, Chilukuri DM. (2001). Cubic phase gels as drug delivery systems. Adv Drug Delivery Rev 47:229–50.
  • Srinivas L, Sagar S. (2022). Design, optimization, and evaluation of raft forming gastro retentive drug delivery system of lafutidine using Box–Behnken design. Int J Appl Pharma 14:266–74.
  • Sugano K. (2013). Single-tablet double-dose famotidine plus ibuprofen decreases endoscopic upper GI ulcers compared with ibuprofen alone. EBM 18:26–7.
  • Szekalska M, Puciłowska A, Szymańska E, et al. (2016). Alginate: current use and future perspectives in pharmaceutical and biomedical applications. Int J Poly Sci 2016:2016–33.
  • Taha AS. (2015). The ibuprofen-famotidine combined pill—a promise fulfilled. Curr Med Res Opin 31:421–2.
  • Teaima MH, Abdel Hamid MM, Shoman NA, et al. (2020). Formulation, characterization and comparative pharmacokinetic study of bupropion floating raft system as a promising approach for treating depression. J Pharm Sci 109:3451–61.
  • Teaima M, Hamid MMA, Shoman NA, et al. (2020). Promising swellable floating bupropion tablets: formulation, in vitro/in vivo evaluation and comparative pharmacokinetic study in human volunteers. Drug Des Devel Ther 14:2741.
  • Tjandrawinata RR, Setiawati A, Nofiarny D, et al. (2018). Pharmacokinetic equivalence study of nonsteroidal anti-inflammatory drug etoricoxib. Clin Pharmacology Adv Appl 10:43–51.
  • Vaughn CJ. (2012). Drugs and lactation database: LactMed. J Elect Res Med Lib 9:272–7.
  • Wang S-Q, Huang G-Q, Du Y-L, Xiao J-X. (2017). Modification of konjac glucomannan by reduced-pressure radio-frequency air plasma. Int J Food Eng 13:20160377.
  • Wang L-X, Lee A-R, Yuan Y, et al. (2020). Preparation and FTIR, Raman and SEM characterizations of konjac glucomannan-KCl electrogels. Food Chem 331:127289.
  • Wei X, Cui C, Fan C, et al. (2022). Injectable hydrogel based on dodecyl-modified N-carboxyethyl chitosan/oxidized konjac glucomannan effectively prevents bleeding and postoperative adhesions after partial hepatectomy. Int J Biol Macromol 199:401–12.
  • WMA – The World Medical Association – WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects. (n.d.). Available at: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/
  • Xu Z, Zhang L, Bentil SA, Bratlie KM. (2021). Gellan gum-gelatin viscoelastic hydrogels as scaffolds to promote fibroblast differentiation. Mater Sci Eng C Mater Biol Appl 129:112370.
  • Yamamoto A, Itoh T, Nasu R, Nishida R. (2014). Sodium alginate ameliorates indomethacin-induced gastrointestinal mucosal injury via inhibiting translocation in rats. WJG 20:2641–52.
  • Yu H, Huang A, Xiao C. (2006). Characteristics of konjac glucomannan and poly(acrylic acid) blend films for controlled drug release. J Appl Polym Sci 100:1561–70.
  • Yuan Y, Hunt RH. (2007). Global gastrointestinal safety profile of etoricoxib and lumiracoxib. Curr Pharm Des 13:2237–47.
  • Zhang Y, Huo M, Zhou J, et al. (2010). DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J 12:263–71.
  • Zhang Y, Huo M, Zhou J, Xie S. (2010). PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Meth Prog Biomed 99:306–14.
  • Zhang W, Ren X, Zhang L, Chen J. (2022). Preparation and performance of thickened liquids for patients with konjac glucomannan-mediated dysphagia. Molecules (Basel, Switzerland) 27:2194–213.
  • Zhao Y, Jayachandran M, Xu B. (2020). In vivo antioxidant and anti-inflammatory effects of soluble dietary fiber konjac glucomannan in type-2 diabetic rats. Int J Biol Macromol 159:1186–96.
  • Zhao C-X, Wang J-W, Gong M. (2020). Efficacy and safety of alginate formulations in patients with gastroesophageal reflux disease: a systematic review and meta-analysis of randomized controlled trials. Eur Rev Med Pharmacology Sci 24:11845–57.